Helping decision-makers, program managers, and funding partners achieve maximum impact with the funding available for the HIV response and plan for sustainability.

Optima HIV helps to:

  • Identify HIV programs to be prioritized with available funding.
  • Determine resources required to reach HIV coverage targets and epidemiological objectives.
  • Consider the country's HIV burden trends and how these change under different funding scenarios.
  • Establish the most cost-effective mix of HIV intervention to respond to a country's HIV epidemic.
  • Reveal the investment allocation and coverage allocation for minimizing HIV incidence, HIV-related mortality, or both.
  • Calculate future treatment, care, and support costs for people affected by HIV or AIDS.
  • Determine the number of new HIV infections and HIV-related deaths averted through existing or optimal investment.

The Optima HIV model was created in 2004 and has since been applied in over 40 countries worldwide. Findings from Optima HIV applications and studies have been used to inform the United Nations General Assembly, Global Fund to Fight AIDS, Tuberculosis and Malaria, Association of Southeast Asian Nations, National HIV/AIDS Strategic Plans, national Global Fund Concept Note applications, and country reports. Optima HIV results can be used to improve country and health policy decision-making by informing domestic and donor public health funding allocations towards better achieving HIV targets.